Healthcare Services

Avian Flu Treatment Market Growth Expected to Reach $20.59 Billion by 2030 with 8.2% CAGR

March 30, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Avian Flu Treatment Market Over The 2026–2030 Period?

The avian flu treatment market has experienced robust expansion over recent years. Projections indicate it will expand from $13.77 billion in 2025 to $15.04 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 9.3%. Historically, this growth can be attributed to several factors: the rising occurrence of avian influenza outbreaks, dependence on antiviral stockpiling strategies, governmental disease control programs, the broadening of hospital-based infectious disease treatment, and enhanced public health awareness.

The avian flu treatment market is projected to experience substantial growth in the upcoming years, with its size anticipated to reach $20.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This expected expansion during the forecast period is largely driven by factors such as heightened investments in zoonotic disease research, the advancing development of next-generation vaccines, the broadening of global disease surveillance networks, an increased emphasis on rapid response therapeutics, and strengthened international collaboration for pandemic preparedness. Key trends emerging in this period include a greater adoption of advanced antiviral therapies, an intensifying focus on platforms for rapid vaccine development, the growing application of monoclonal antibody treatments, the expansion of early diagnosis and surveillance initiatives, and an amplified concentration on pandemic preparedness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp

What Drivers Are Expected To Influence The Avian Flu Treatment Market During The Forecast Period?

Increased understanding and identification of avian flu are anticipated to fuel expansion in the avian flu treatment market. Awareness involves perceiving a condition, whereas diagnosis pinpoints a particular problem stemming from that perception. The necessity for avian flu treatment stems from the critical imperative to protect public health, avert potential global outbreaks, and shield poultry industries from substantial financial damage. Prompt recognition and diagnosis are vital for successful avian flu management, facilitating swift action and control to stop its proliferation. For instance, the World Health Organization (WHO), an intergovernmental body based in Switzerland, reported in April 2024 that over 8000 individuals in the US were actively monitored between February 9, 2022, and March 29, 2024, following exposure to animals suspected of carrying the HPAI A (H5N1) virus. Consequently, heightened awareness and diagnostic efforts are propelling the growth of the avian flu treatment market.

How Is The Avian Flu Treatment Market Segmented Across Key Categories?

The avian flu treatment market covered in this report is segmented –

1) By Type: Vaccines, Antiviral Agents, Immunoglobulins

2) By Distribution Channel: Online Pharmacies, Offline Pharmacies

3) By End User: Hospital, Institutional Health Centers, Clinics

Subsegments:

1) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines

2) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), Polymerase Inhibitors, Antiviral Combination Therapies

3) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins

What Major Market Trends Are Driving Changes In The Avian Flu Treatment Market?

Companies operating in the avian flu treatment market are primarily focusing on establishing partnerships to enhance efficacy and expedite the development of new therapies. These partnerships involve collaborations between pharmaceutical enterprises, research institutions, and government bodies to consolidate resources, share expertise, and conduct innovative clinical trials. A notable example occurred in April 2024, when CureVac N.V., a Germany-based biotechnology firm, partnered with GSK plc, a UK-based pharmaceutical company, to create an investigative influenza A (H5N1) pre-pandemic vaccine candidate aimed at addressing the potential future pandemic risk posed by the H5N1 avian influenza virus. This specific collaboration intends to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which encodes an influenza A H5 antigen using CureVac’s proprietary second-generation mRNA backbone. The upcoming combined Phase 1/2 study will assess the vaccine candidate’s safety and effectiveness in healthy adults aged 18 to 64, as well as in older adults aged 65 to 85.

Who Are The Dominant Players Shaping The Avian Flu Treatment Market Landscape?

Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline Plc, Novartis AG, AstraZeneca Plc, Gilead Sciences Inc., CSL Limited, Moderna Inc., Shionogi & Co. Ltd., Cipla Ltd., Seqirus, Novavax Inc., Sinovac Biotech Ltd., Valneva SE, CureVac AG, BioCryst Pharmaceuticals Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Baxter International Inc., Takeda Pharmaceutical Company Limited

Read the full avian flu treatment market report here:

https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

Which Region Is Forecast To Lead The Avian Flu Treatment Market In Terms Of Market Size?

North America was the largest region in the avian flu treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Avian Flu Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16352&type=smp

Browse Through More Reports Similar to the Global Avian Flu Treatment Market 2026, By The Business Research Company

Influenza Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Swine Flu Vaccination Global Market Report

https://www.thebusinessresearchcompany.com/report/swine-flu-vaccination-global-market-report

Influenza Vaccines Global Market Report

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795